Contemporary Diagnosis and Management of Prostate Cancer

Dear Colleagues,

We are pleased to announce the upcoming Special Issue of Cancers, focusing on the "Contemporary Diagnosis and Management of Prostate Cancer". Prostate cancer is one of the most common cancers in men, and advancements in diagnosis and treatment have greatly impacted patient outcomes. This Special Issue aims to provide a comprehensive overview of the latest developments in the field, covering various aspects of prostate cancer diagnosis and management. We invite the submission of original research articles and reviews that cover various aspects of prostate cancer, including but not limited to the following:

1. Contemporary diagnosis and staging of prostate cancer (focusing on biomarker, imaging, and biopsy techniques);
2. Active surveillance of prostate cancer (focusing on patient selection and outcomes);
3. Radical prostatectomy for clinically localized and locally advanced prostate cancer (focusing on open vs. robotic-assisted laparoscopic radical prostatectomy, patient selection, surgical techniques, and patient outcomes);
4. Radiation therapy for clinically localized and locally advanced prostate cancer (focusing on IMRT, proton beam therapy, brachytherapy, patient selection, and patient outcomes);
5. Adjuvant and salvage therapies for high-risk and/or recurrent prostate cancer following radical prostatectomy.

All submitted articles will undergo a rigorous peer-review process to ensure the highest scientific quality and relevance to the field. We encourage contributions from researchers, clinicians, and experts in the field of urology and prostate cancer.

By consolidating the latest research findings and clinical experiences, we aim to enhance our understanding of radical prostatectomy and improve patient outcomes. We believe that your valuable contributions will significantly contribute to the success of this Special Issue.

Should you have any questions, require further information, or need any assistance, please do not hesitate to reach out to us. We are here to support and facilitate your participation in this Special Issue.

We look forward to receiving your submissions. 

Dr. Thomas Jang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• prostate cancer
• diagnosis
• management
• radical prostatectomy
• biomarkers